{"id":11122,"date":"2023-03-07T00:00:00","date_gmt":"2023-03-07T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/"},"modified":"2025-08-19T08:28:12","modified_gmt":"2025-08-19T13:28:12","slug":"revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/","title":{"rendered":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)"},"content":{"rendered":"<p><em>Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province.<\/em><\/p>\n<p><em>\u201cWe are pleased to now offer this revolutionary CAR T therapy in Saskatchewan, so that patients no longer need to travel out of province to take advantage of this potentially lifesaving treatment,\u201d Saskatchewan Cancer Agency President and CEO Deb Bulych said. \u201cThis exciting announcement would not be possible without the steadfast support from the Government of Saskatchewan, the Saskatchewan Health Authority and our health system partners.\u201d<\/em><\/p>\n<p><a class=\"ButtonSimple\" href=\"\/pixms\/uploads\/serve\/ckeditor\/1nr_car_t_therapy_announcement_17_feb_2023.pdf\" target=\"_blank\" rel=\"noopener\">Cliquez ici pour lire la suite<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11122","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-03-07T05:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T13:28:12+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#blogposting\",\"name\":\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\\u00e9lome Canada\",\"headline\":\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2023-03-07T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:12-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#webpage\"},\"articleSection\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement, News &amp; Events, Nouvelles de My\\u00e9lome Canada, What's new at Myeloma Canada, Facultatif, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"name\":\"News &amp; Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"position\":2,\"name\":\"News &amp; Events\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"name\":\"What's new at Myeloma Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"position\":3,\"name\":\"What's new at Myeloma Canada\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#listItem\",\"name\":\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"name\":\"News &amp; Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#listItem\",\"position\":4,\"name\":\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"name\":\"What's new at Myeloma Canada\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/\",\"name\":\"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\\u00e9lome Canada\",\"description\":\"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \\u201cWe\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/07\\\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2023-03-07T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:12-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada","description":"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe","canonical_url":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#blogposting","name":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada","headline":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2023-03-07T00:00:00-05:00","dateModified":"2025-08-19T08:28:12-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#webpage"},"articleSection":"Actualit\u00e9s et \u00e9v\u00e9nement, News &amp; Events, Nouvelles de My\u00e9lome Canada, What's new at Myeloma Canada, Facultatif, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","name":"News &amp; Events"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","position":2,"name":"News &amp; Events","item":"https:\/\/myeloma.ca\/category\/news-events\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","name":"What's new at Myeloma Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","position":3,"name":"What's new at Myeloma Canada","item":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#listItem","name":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","name":"News &amp; Events"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#listItem","position":4,"name":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT)","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","name":"What's new at Myeloma Canada"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/","name":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada","description":"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2023-03-07T00:00:00-05:00","dateModified":"2025-08-19T08:28:12-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada","og:description":"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe","og:url":"https:\/\/myeloma.ca\/fr\/2023\/03\/07\/revolutionary-car-t-therapy-now-available-for-patients-with-specific-cancers-in-saskatchewan-en-anglais-seulement\/","article:published_time":"2023-03-07T05:00:00+00:00","article:modified_time":"2025-08-19T13:28:12+00:00","twitter:card":"summary_large_image","twitter:title":"REVOLUTIONARY CAR T THERAPY NOW AVAILABLE FOR PATIENTS WITH SPECIFIC CANCERS IN SASKATCHEWAN (EN ANGLAIS SEULEMENT) | My\u00e9lome Canada","twitter:description":"Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to home. The Saskatchewan Cancer Agency (Cancer Agency), along with the Saskatchewan Health Authority (SHA), is launching the revolutionary Chimeric Antigen Receptor T-cell (CAR T) therapy to treat adult cancer patients with certain blood cancers and lymphomas in the province. \u201cWe"},"aioseo_meta_data":{"post_id":"11122","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-09-18 15:58:40","updated":"2026-04-30 07:11:01","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11122"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11122\/revisions"}],"predecessor-version":[{"id":31269,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11122\/revisions\/31269"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}